Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#2090
ANI Pharmaceuticals, Inc.
76.480
0
USD
-2.31%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-2.31%
Mudança mensal
+8.07%
Mudança em 6 meses
-19.18%
Mudança anual
-19.18%
Fechamento anterior
78.290
0
Abrir
76.480
0
Bid
Ask
Mínimo
76.480
0
High
76.480
0
Volume
49
Mercados
Ações
Cuidados de saúde
ANIP
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
21.76 M
21.65 M
21.69 M
22.46 M
22.41 M
—
Valuation ratios
Enterprise value
1.38 B
1.62 B
1.51 B
2.11 B
1.79 B
7.03 B
Price to earnings ratio
-53.15
-57.22
-97.39
52.95
23.78
-77.89
Price to sales ratio
1.74
1.94
1.73
2.24
1.9
7.81
Price to cash flow ratio
16.68
16.29
9.4
10.92
9.05
45.65
Price to book ratio
2.65
0.78
0.77
1.05
3.1
5.7
Enterprise value to EBITDA ratio
10.05
8.4
6.92
7.31
6.05
28.68
Profitability ratios
Return on assets %
-0.01
0.01
0.01
0.02
0.02
0.06
Return on equity %
-0.03
0.04
0.02
0.05
0.05
0.16
Return on invested capital %
-1.22
7.62
4.23
10.78
11.36
34
Gross margin %
57.87
62.95
64.7
59.01
59.42
246.07
Operating margin %
-2.3
13.29
6.57
15.91
14.07
49.84
EBITDA margin %
41.37
35.57
27.73
34.95
56.76
155
Net margin %
-5.39
7.95
4.04
11.68
11.13
34.81
Liquidity ratios
Quick ratio
2.02
1.98
1.96
2.04
2.19
8.17
Current ratio
2.72
2.66
2.54
2.58
2.71
10.49
Inventory turnover
0.56
0.53
0.54
0.66
0.69
2.42
Asset turnover
0.15
0.15
0.16
0.17
0.17
0.65
Solvency ratios
Debt to assets ratio
0.25
0.24
0.23
0.22
0.21
0.92
Debt to equity ratio
0.79
0.76
0.72
0.62
0.57
2.67
Long term debt to total assets ratio
0.24
0.24
0.22
0.21
0.2
0.87
Long term debt to total equity ratio
0.77
0.73
0.69
0.59
0.54
2.55
Per share metrics
Operating cash flow per share
0.82
1.75
3.73
2.09
1.43
9
EBIT per share
-0.23
1.31
0.68
1.72
1.64
5.35
EBITDA per share
4.08
3.5
2.89
3.77
6.61
16.76
Total debt per share
16.49
15.79
15.5
14.84
14.57
60.69
Cash per share
7.5
7.47
10.72
12.45
13.45
44.1
Net current asset value per share
27.32
26.75
29.67
33.11
35.48
125.02
Tangible book value per share
-10.26
-9.01
-7.1
-2.68
-0.06
-18.84
Working capital per share
17.29
16.69
18.01
20.28
22.38
77.36
Book value per share
20.9
20.88
21.51
23.98
25.47
91.84
Notícias
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
ANI Pharmaceuticals lança comprimidos genéricos de mononitrato de isossorbida
ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD